Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 542175 of 542236 entries
View as:

External Validation of Clinical Prediction Tools for Estimating Salt and Potassium Intake in Nephrology Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05783960 Org: User:
Start: 07/16/23 End: 07/10/24 Due: 07/10/25

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

Phase: N/A Priority: Normal
NCT ID: NCT03671148 Org: User:
Start: 03/07/19 End: 06/12/26 Due: 06/12/27

Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05233917 Org: User:
Start: 06/09/23 End: 12/22/23 Due: 12/22/24

Regorafenib in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02098538 Org: User:
Start: 03/31/14 End: 11/07/24 Due: 11/07/25

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05712889 Org: User:
Start: 01/24/23 End: 10/10/24 Due: 10/10/25

Reticulospinal Control of Movements

Phase: N/A Priority: Normal
NCT ID: NCT04967274 Org: User:
Start: 01/15/22 End: 06/30/26 Due: 06/30/27

Attitude and Success Rate of Women with Pelvic Organ Prolapse on Self-management of Vaginal Pessary

Phase: N/A Priority: Normal
NCT ID: NCT06246721 Org: User:
Start: 02/02/24 End: 12/15/25 Due: 12/15/26

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

Phase: N/A Priority: Normal
NCT ID: NCT04717908 Org: User:
Start: 01/20/21 End: 06/22/24 Due: 06/22/25

Lumbar Vein Embolization for Chronic Headaches with Nutcracker Physiology

Phase: N/A Priority: Normal
NCT ID: NCT06077747 Org: User:
Start: 09/17/24 End: 09/30/27 Due: 09/30/28

A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT06644768 Org: User:
Start: 10/30/24 End: 04/30/30 Due: 04/30/31

Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.

Phase: N/A Priority: Normal
NCT ID: NCT04276480 Org: User:
Start: 02/16/22 End: 04/22/24 Due: 04/22/25

Endoscopic FHL Transfer for Acute Achilles Tendon Rupture

Phase: N/A Priority: Normal
NCT ID: NCT06641401 Org: User:
Start: 03/05/23 End: 12/30/25 Due: 12/30/26

From Administration of Oral Medicines by Nurses to Controlled Self-administration: Impact on Safety of Administration During Hospitalisation

Phase: N/A Priority: Normal
NCT ID: NCT06639113 Org: User:
Start: 05/24/24 End: 05/31/26 Due: 05/31/27

First-degree Ankle Sprains

Phase: N/A Priority: Normal
NCT ID: NCT06645262 Org: User:
Start: 06/12/24 End: 12/01/24 Due: 12/01/25

Acupuncture for Functional Constipation in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05496543 Org: User:
Start: 10/10/22 End: 09/30/24 Due: 09/30/25

A Neuro-Technological Intervention for Adolescents With GAD

Phase: N/A Priority: Normal
NCT ID: NCT03813290 Org: User:
Start: 12/08/20 End: 01/31/26 Due: 01/31/27

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Phase: N/A Priority: Normal
NCT ID: NCT01966120 Org: User:
Start: 10/31/13 End: 04/30/15 Due: 04/30/16

To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03390673 Org: User:
Start: 09/19/18 End: 03/13/19 Due: 03/13/20

Lorlatinib Continuation Study

Phase: N/A Priority: Normal
NCT ID: NCT05144997 Org: User:
Start: 12/28/21 End: 12/28/26 Due: 12/28/27

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

Phase: N/A Priority: Normal
NCT ID: NCT02043847 Org: User:
Start: 01/14/14 End: 09/14/16 Due: 09/14/17

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03093870 Org: User:
Start: 07/04/17 End: 04/17/20 Due: 04/17/21

Developing Inclusive Youth: Promoting Intergroup Friendships and Inclusive Classrooms in Childhood

Phase: N/A Priority: Normal
NCT ID: NCT05619523 Org: User:
Start: 09/27/22 End: 01/31/24 Due: 01/31/25

A Drug-Drug Interaction Study of Digoxin and PA21

Phase: N/A Priority: Normal
NCT ID: NCT01477411 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

Effects of Journaling on Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT01660685 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

Home Exercise Adherence in Physical Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02822755 Org: User:
Start: 06/30/16 End: 09/30/18 Due: 09/30/19